Cross-species oncolytic virotherapy in vitro: BoHV4EGFPΔTK as a novel candidate against canine osteosarcoma and histiocytic sarcoma.
- DOI
- 10.1007/s11259-026-11428-5
- Published
- 2026 Jul 28
- Container
- Veterinary research communications
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s11259-026-11428-5,
title = {Cross-species oncolytic virotherapy in vitro: BoHV4EGFPΔTK as a novel candidate against canine osteosarcoma and histiocytic sarcoma.},
author = {Melania DP and Sergio M and Valentina F and Rosanna DL and Attilio C and Paolo B and Gaetano D and Elisabetta R and Floriana F and Wolfgang B and Rosanna V and Melania A and Giuseppina B and Simona B and Benedetta P and Federico A},
year = {2026},
journal = {Veterinary research communications},
doi = {10.1007/s11259-026-11428-5},
url = {https://doi.org/10.1007/s11259-026-11428-5}
}RIS
TY - JOUR TI - Cross-species oncolytic virotherapy in vitro: BoHV4EGFPΔTK as a novel candidate against canine osteosarcoma and histiocytic sarcoma. AU - Melania DP AU - Sergio M AU - Valentina F AU - Rosanna DL AU - Attilio C AU - Paolo B AU - Gaetano D AU - Elisabetta R AU - Floriana F AU - Wolfgang B AU - Rosanna V AU - Melania A AU - Giuseppina B AU - Simona B AU - Benedetta P AU - Federico A PY - 2026 JO - Veterinary research communications DO - 10.1007/s11259-026-11428-5 UR - https://doi.org/10.1007/s11259-026-11428-5 ER -
APA
DP, M., M, S., F, V., DL, R., C, A., B, P., D, G., R, E., F, F., B, W., V, R., A, M., B, G., B, S., P, B., & A, F. (2026). Cross-species oncolytic virotherapy in vitro: BoHV4EGFPΔTK as a novel candidate against canine osteosarcoma and histiocytic sarcoma.. Veterinary research communications. https://doi.org/10.1007/s11259-026-11428-5
Source records
- pubmed · retrieved 2026-09-25T11:30:01.441Z